ArticleOncotarget2016

Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor.

Konstantinos Alevizopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.